Archives
US SEC calls on Nasdaq and NYSE to explain trading halt
The US Securities and Exchange Commission called rival exchange operators Nasdaq and NYSE to give details on the three hour trading halt which occurred last week.
Guessing game starts for new Microsoft CEO
CEO Steve Ballmer had announced resignation from Microsoft leaving the company with no apparent heir.
Akorn Inc. to purchase Hi-Tech Pharmacal Co.
Today, Akorn Inc. and Hi-Tech Pharmacal Co. announced they had signed a definitive acquisition agreement valued USD640 million in cash.
Bats stock data increases from merger
According to Bats Global Markets Inc. CEO Joe Ratterman, the merger of Bats and Direct Edge Holdings Inc. had raised stock data.
Latest News
The AMR-US Airways merger could be blocked by Federal regulators which had made JetBlue Airways the next target once the US Department of Justices succeeds in derailing the deal.
Former JP Mogran & Chase trader Javier Martin-Artajo had been released from policy custody after he had kept trading losses that cost the bank USD6.2 billion losses.
The National Dog Day was founded to encourage the adoption of shelter strays as pets. August 26 is National Dog Day. This celebration started back in 2004 in recognition of the high number of shelter pets that seek a good home.
Eminem signals his return to the music scene through the release of his new album 'MMLP2'.
NCAA's investment portfolio is now valued at USD 527 million as its quasi-endowment and operating reserve posted gains of 11%.
Generic eye drug manufacturer Akorn said that it would be buying Hi-Tech Pharmacal Co Inc in a deal worth USD 640 million.
Tracy McGrady hangs up his sneakers after 16 years in the NBA. In a message made at ESPN's First Take, Tracy McGrady announced, "It's been 16 years playing the game I love.
Venus and Serena Williams led wins in the first day of the US Open, reminiscent of their success in previous years.
French oil and gas company Total said that it would be buying the retail network of US-based Chevron in Egypt.
AstraZeneca has been looking at another acquisition deal even after spending almost USD1 billion in acquisitions earlier this year.